Search for: "Johnson v. Howes" Results 221 - 240 of 3,896
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Jun 2023, 7:09 pm by Jacob Fishman
Part V concludes with a report card on how the regime is doing on its thirtieth anniversary. [read post]
19 Jun 2023, 2:00 am by INFORRM
The Information Commissioner’s Office (ICO) is paying greater attention to how companies use cookies on websites and how they allow users to configure their settings. [read post]
16 Jun 2023, 9:30 pm by ernst
 There is still time to register for the Supreme Court Historical Society's commemoration of Juneteenth, a conversation with Judge Curtis Collier and the Society’s Executive Director, Jim Duff, on the lynching of Ed Johnson in 1906 and the resulting US Supreme Court decisions, United States v. [read post]
12 Jun 2023, 12:53 am by INFORRM
Johnson J held that the comments were defamatory in a preliminary trial of the claim on 25 July 2022. [read post]
9 Jun 2023, 9:07 am by Bill Marler
, Stx1, Stx2, Stx2c), and acts like the plant toxin ricin by inhibiting protein synthesis in endothelial and other cells. [16]   Endothelial cells line the interior surface of blood vessels and are known to be extremely sensitive to E. coliO157:H7, which is cytotoxigenic to these cells. [16] In addition to Shiga toxin, E. coli O157:H7 produces numerous other putative virulence factors, including proteins which aid in the attachment and colonization of the… [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Among the two most significant was a 2016 complaint by Pfizer alleging that claimed that Johnson & Johnson—the maker of Remicade, a best-selling medication for autoimmune disease—threatened not to pay rebates to PBMs unless they excluded from their formulary Pfizer’s biosimilar imitator to Remicade: Inflectra. [read post]
8 Jun 2023, 7:43 am by Ashwin Varma
Among the two most significant was a 2016 complaint by Pfizer alleging that claimed that Johnson & Johnson—the maker of Remicade, a best-selling medication for autoimmune disease—threatened not to pay rebates to PBMs unless they excluded from their form [read post]